WO2001096398A3 - Proteines bruleuses de graisses excedentaires utilisees comme cibles dans le traitement de l'insuffisance cardiaque - Google Patents
Proteines bruleuses de graisses excedentaires utilisees comme cibles dans le traitement de l'insuffisance cardiaque Download PDFInfo
- Publication number
- WO2001096398A3 WO2001096398A3 PCT/US2001/019230 US0119230W WO0196398A3 WO 2001096398 A3 WO2001096398 A3 WO 2001096398A3 US 0119230 W US0119230 W US 0119230W WO 0196398 A3 WO0196398 A3 WO 0196398A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- heart failure
- treatment
- targets
- uncoupling proteins
- present
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001268461A AU2001268461A1 (en) | 2000-06-15 | 2001-06-15 | Uncoupling proteins as targets for the treatment of heart failure |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21153600P | 2000-06-15 | 2000-06-15 | |
US60/211,536 | 2000-06-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001096398A2 WO2001096398A2 (fr) | 2001-12-20 |
WO2001096398A3 true WO2001096398A3 (fr) | 2002-05-16 |
Family
ID=22787332
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/019230 WO2001096398A2 (fr) | 2000-06-15 | 2001-06-15 | Proteines bruleuses de graisses excedentaires utilisees comme cibles dans le traitement de l'insuffisance cardiaque |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001268461A1 (fr) |
WO (1) | WO2001096398A2 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1573045A4 (fr) * | 2002-11-27 | 2007-02-21 | Artesian Therapeutics Inc | Detection des genes lies a l'insuffisance cardiaque et dosage therapeutique |
US9068183B2 (en) | 2009-12-23 | 2015-06-30 | Curna, Inc. | Treatment of uncoupling protein 2 (UCP2) related diseases by inhibition of natural antisense transcript to UCP2 |
CA2916977A1 (fr) * | 2013-06-26 | 2014-12-31 | Stealth Biotherapeutics Corp | Methodes et compositions destinees a detecter et a diagnostiquer des maladies et des affections |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998045313A1 (fr) * | 1997-04-04 | 1998-10-15 | Amylin Pharmaceuticals, Inc. | Proteine decouplante et procedes d'utilisation |
-
2001
- 2001-06-15 WO PCT/US2001/019230 patent/WO2001096398A2/fr active Application Filing
- 2001-06-15 AU AU2001268461A patent/AU2001268461A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998045313A1 (fr) * | 1997-04-04 | 1998-10-15 | Amylin Pharmaceuticals, Inc. | Proteine decouplante et procedes d'utilisation |
Non-Patent Citations (4)
Title |
---|
GENG Y-J ET AL: "APOPTOSIS OF CARDIAC MYOCYTES IN GSALPHA TRANSGENIC MICE", CIRCULATION RESEARCH, GRUNE AND STRATTON, BALTIMORE, US, vol. 84, no. 1, 8 January 1999 (1999-01-08), pages 34 - 42, XP001007327, ISSN: 0009-7330 * |
KELLY LINDA J ET AL: "Peroxisome proliferator-activated receptors gamma and alpha mediated in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) gene expression.", ENDOCRINOLOGY, vol. 139, no. 12, December 1998 (1998-12-01), pages 4920 - 4927, XP002182349, ISSN: 0013-7227 * |
SILVA J ENRIQUE ET AL: "Regulation of the uncoupling protein gene expression.", EUROPEAN JOURNAL OF ENDOCRINOLOGY, vol. 136, no. 3, 1997, pages 251 - 264, XP000918584, ISSN: 0804-4643 * |
VAN DER LEE KARIN A J M ET AL: "Effects of fatty acids on uncoupling protein-2 expression in the rat heart.", FASEB JOURNAL, vol. 14, no. 3, March 2000 (2000-03-01), pages 495 - 502, XP002182350, ISSN: 0892-6638 * |
Also Published As
Publication number | Publication date |
---|---|
AU2001268461A1 (en) | 2001-12-24 |
WO2001096398A2 (fr) | 2001-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1999043651A3 (fr) | Inhibiteurs d'enzymes phospholipases | |
CA2359116A1 (fr) | Porphyrines substituees | |
WO2003073999A3 (fr) | Composes de modulation de pin1 et procedes d'utilisation correspondant | |
IL148079A0 (en) | Human ctla-4 antibodies and compositions containing the same | |
WO2003074550A3 (fr) | Composes de modulation de pin1 et procedes d'utilisation correspondant | |
AU1565300A (en) | Anti-germinating method for tubers and bulbs using eugenol and/or isoeugenol | |
WO2001017543A3 (fr) | Compositions et procedes permettant la prevention ou le traitement du cancer et de la perte osseuse associee au cancer | |
HK1064950A1 (en) | Methods for treating or preventing vascular inflammation using sterol absorption inhibitor(s) | |
ZA971183B (en) | Benzamidine derivatives substituted by amino acid and hydroxy acid derivatives and their use as anti-coagulants. | |
WO2002091858A8 (fr) | Compositions anxiolytiques de marcgraviaceae contenant de l'acide betulinique ou des derives d'acide betulinique et procedes associes | |
TW200640944A (en) | VGF polypeptides and methods of treating VGF-related disorders | |
WO2003010291A3 (fr) | Traitement de troubles concernant les cellules immunitaires et les cellules b | |
EP1254260A4 (fr) | Methodes pour diagnostiquer et traiter une maladie du coeur | |
WO2000040232A3 (fr) | Nouvelles compositions et trousses de bretylium, et leur utilisation dans la prevention et le traitement des pathologies cardio-vasculaires | |
IL143516A0 (en) | COMPOUNDS AND METHODS FOR MODULATING ACTIVATION OF NF-k-B | |
MXPA02000680A (es) | Polipeptidos vgf y metodos para tratar desordenes relacionados con vgf. | |
EP0861663A3 (fr) | Agent inhibiteur des ostéoclastes comprenant l'interleukin-18 | |
WO2001096398A3 (fr) | Proteines bruleuses de graisses excedentaires utilisees comme cibles dans le traitement de l'insuffisance cardiaque | |
EP1028754A4 (fr) | Prevention d'une immunoreactivite par depletion ou inhibition de cellules presentant l'antigene | |
WO2002062205A3 (fr) | Methodes de diagnostic et de traitement des cardiopathies | |
WO2003087840A3 (fr) | Proteine intervenant dans le cancer | |
WO2003017817A3 (fr) | Diagnostic, prevention et traitement du cancer | |
WO2003028536A3 (fr) | Methodes permettant de diagnostiquer et de traiter les maladies cardiaques | |
WO1999050671A3 (fr) | Proteine toso comme cible de criblage de medicaments | |
AU7028798A (en) | Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |